ECKERT & ZIEGLER SE
DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Change in Forecast/Forecast Berlin, 23 July 2018. According to initial analyses, the business development of the Berlin based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) was significantly higher as of June 30, 2018 than the comparable value of the prior year. While sales of EUR 64.8 million were generated in 2017 with continuing operations, this value increased by 25 % to EUR 81.0 million as of the half-year reporting date in 2018. In the same period, the earnings from continuing operations increased by 31 % from EUR 1.25 to EUR 1.63 per share. Since the 2018 half-year result contains only a few extraordinary effects and the good business development included almost all of the main product groups, the Executive Board now assumes that the consolidated earnings from continuing operations will increase by at least 15 % for the fiscal year 2018 compared to the prior year. The previous target of EUR 2.20 therefore increases to around EUR 2.50 per share. The complete figures for the first half year 2018 will be published on 31 July 2018.
Your contact:
23-Jul-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | 49 30 941084-138 |
| Fax: | 49 30 941084-112 |
| E-mail: | karolin.riehle@ezag.de |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| End of Announcement | DGAP News Service |
707131 23-Jul-2018 CET/CEST
